iLumisAR
Aurora, US · Founded 2022 · Delaware corporation
Founders & leadership
MD
Mark DayExecutive
MS
Michael StraightiffNamed on SEC filing
MM
Matthew MillerNamed on SEC filing
Board
LL
Lia LogioBoard director
AS
Abinav SankarBoard director
NW
Neil WyantBoard director
Reported raises · per SEC filings
Form D private placements$5.3M disclosed across 2 rounds · 2024–2025
▶$2.1MraisedJan 2026 · 7 investors · Other TechnologyRule 506(b)
▶$2.1MraisedJan 2026 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Lia LogioDirector
- Mark DayExecutive Officer, Director
- Abinav SankarDirector
- Neil WyantDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$3.2MraisedFeb 2024 · 6 investors · BiotechnologyRule 506(b)
▶$3.2MraisedFeb 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael StraightiffDirector
- Matthew MillerDirector
- Mark DayExecutive Officer, Director
- Abinav SankarDirector
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has iLumisAR raised?
- iLumisAR has disclosed $5.3M raised across 2 rounds.
- Where is iLumisAR headquartered?
- iLumisAR is headquartered in Aurora, US.